AVITA Medical (RCEL) EBIT Margin (2018 - 2025)
AVITA Medical (RCEL) posted EBIT Margin of 11.31% for Q4 2025, up 79.12% on a QoQ basis from 54.17% in Q3 2025, and up 4386.0% year-over-year from 0.25% in Q4 2024.
AVITA Medical (RCEL) EBIT Margin (2018 - 2025) Analysis & Trends
AVITA Medical's EBIT Margin history runs 8 years deep, the most recent figure standing at 11.31% for Q4 2025.
- Quarterly EBIT Margin rose 4386.0% year-over-year to 11.31% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 29.24% (up 5933.0% YoY) and the FY2025 annual result came in at 59.4%, up 2918.0% from the prior year.
- EBIT Margin was 11.31% for Q4 2025 at AVITA Medical, up from 54.17% in the prior quarter.
- Across five years, EBIT Margin topped out at 11.31% in Q4 2025 and bottomed at 154.95% in Q1 2024.
- A 5-year average of 77.8% and a median of 68.28% in 2021 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2021 — EBIT Margin surged 32902 bps — and 2024, when it tumbled 6101 bps.
- AVITA Medical's EBIT Margin stood at 63.8% in 2021, then plunged by 64 bps to 104.71% in 2022, then rose by 17 bps to 86.46% in 2023, then soared by 36 bps to 55.17% in 2024, then jumped by 79 bps to 11.31% in 2025.
- Business Quant data shows RCEL's EBIT Margin at 11.31% in Q4 2025, 54.17% in Q3 2025, and 61.17% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | -11.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.31% |
| Sep 30, 2025 | -54.17% |
| Jun 30, 2025 | -61.17% |
| Mar 31, 2025 | -64.54% |
| Dec 31, 2024 | -55.17% |
| Sep 30, 2024 | -70.63% |
| Jun 30, 2024 | -102.82% |
| Mar 31, 2024 | -154.95% |
| Dec 31, 2023 | -86.46% |
| Sep 30, 2023 | -68.20% |
| Jun 30, 2023 | -95.00% |
| Mar 31, 2023 | -93.94% |
| Dec 31, 2022 | -104.71% |
| Sep 30, 2022 | -63.22% |
| Mar 31, 2022 | -125.84% |
| Sep 30, 2021 | -63.80% |
| Jun 30, 2021 | -56.09% |
| Mar 31, 2021 | -68.35% |
| Dec 31, 2020 | -110.35% |
| Sep 30, 2020 | -201.86% |